Specialty R&D pipeline


Therapy Molecule Indication MoA/Class
Pre-Clinical Phase 1 Phase 2 a Phase 2 b Phase 3 Approval
Respiratory Ryaltris™ - GSP 301 Steroid + AH Allergic Rhinitis
+
 
Respiratory
Respiratory GBR 310 Biosimilar Asthama,CIU
+
 
Respiratory
Respiratory GSP 304 LAMA COPD
+
 
Respiratory
Immunology GRC 39815 ROR y t Inhibitor COPD
+
 
Immunology